The same could be said for many tests that are conducted, as you almost need to look at the quality of life at this age and determine is the cure worth the effort. As long as insurance compensation will pay for those who do want the procedure, then it should be an individual decision on the part of the patient.
One other development that might lend some additional information is the development of a test through genomics that would help determine treatment outcomes from the start. BD
In a move that could lead to significant changes in medical care for older men, a national task force on Monday recommended that doctors stop screening men ages 75 and older for prostate cancer because the search for the disease in this group was causing more harm than good.